Sepsis & infection

Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock

JAMAPublished Retrospective cohort study

Authors' conclusion

The novel Phoenix sepsis criteria, which were derived and validated using data from higher- and lower-resource settings, had improved performance for the diagnosis of pediatric sepsis and septic shock compared with the existing IPSCC criteria.

Study context

Population
Children (<18 years) in emergency and inpatient encounters, 10 health systems in the US, Colombia, Bangladesh, China and Kenya, 2010–201910 health systems
Exposure
Phoenix sepsis criteria vs 2005 International Pediatric Sepsis Consensus Conference (IPSCC) criteria
Outcome
In-hospital mortality (prediction performance: AUPRC primary; PPV and sensitivity for binary criteria)
Methodological detailsmulticentre, international, derivation and external validation, Development set 3 049 699; external validation set 581 317 encounters
  • Multicentre
  • International
  • Derivation and external validation
  • Development set 3 049 699; external validation set 581 317 encounters

Main finding

As reported in the abstract

Prediction of in-hospital mortality, validation sets
GroupArea under the precision recall curve (AUPRC)AUROC
Phoenix0.23 to 0.38 (95% CI range, 0.20-0.39)0.71 to 0.92 (95% CI range, 0.70-0.92)

Phoenix

Area under the precision recall curve (AUPRC)0.23 to 0.38 (95% CI range, 0.20-0.39)
AUROC0.71 to 0.92 (95% CI range, 0.70-0.92)

Observational data: associations, not effects.

Further findings

Model derivation (development set, suspected infection in first 24 h)

Mortality in development set
1.2%
4-organ-system model performed best
  • 172 984 children with suspected infection

Original publication

Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock. JAMA. Published 27 February 2024. doi:10.1001/jama.2024.0196

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.